4//SEC Filing
Kaba Samer 4
Accession 0001267602-19-000192
CIK 0001267602other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:30 PM ET
Size
4.8 KB
Accession
0001267602-19-000192
Insider Transaction Report
Form 4
Kaba Samer
Chief Medical Officer
Transactions
- Award
Common Stock
2019-11-15$4.75/sh+149$708→ 5,367 total
Footnotes (2)
- [F1]These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2019.
- [F2]On November 14, 2019, after the close of business, the issuer effected a one-for-15 reverse stock split, which is reflected in the amount shown in column 5.
Documents
Issuer
ALIMERA SCIENCES INC
CIK 0001267602
Entity typeother
Related Parties
1- filerCIK 0001773634
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 4:30 PM ET
- Size
- 4.8 KB